Archive for 'February,2013'

IBA of Belgium and Apollo Hospitals sign contract to install the first proton therapy center in India.

IBA of Belgium and Apollo Hospitals sign contract to install the first proton therapy center in India.

Headquartered in Louvain-La-Neuve, Belgium, IBA (Ion Beam Applications S.A.), a global high-tech leader in next generation radiation therapy and diagnostics for the treatment of cancer, has signed a contract to establish the first proton therapy center [...]

Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials

Bone Therapeutics completes a €7.7 Million Series D Fundraising round to further advance ongoing PREOB® Phase III clinical trials

Following the approval of the pivotal phase III osteonecrosis trial of PREOB® last November (posted Nov. 9, 2012), Bone Therapeutics has just completed a €7.7 million Series D fundraising round. Of the raised funds, €6.1 million were [...]

TRASIS (Ans, Belgium) gets global recognition with development of the first GMP (Good Manufacturing Practice) universal radiosynthesis unit

TRASIS (Ans, Belgium) gets global recognition with development of the first GMP (Good Manufacturing Practice) universal radiosynthesis unit

Trasis, a Belgian company experienced in the development of innovative solutions for the radiopharmaceutical industry, has joined forces with four local University laboratories in an effort to identify new types of biomarkers and tracers for in [...]

DNAVision(Gosselies, Belgium) among the first in Europe to receive the ISO 17025 accreditation of exome sequencing service for clinical applications.

DNAVision(Gosselies, Belgium) among the first in Europe to receive the ISO 17025 accreditation of exome sequencing service for clinical applications.

An external audit carried out by the Belgian Authorities recently validated DNAVision’s (Gosselies, Belgium) technical competence to carry out exome sequencing* and the ability to consistently produce valid and traceable results. This important validation will allow [...]

Cédric Blanpain receives Liliane Bettencourt Prize for his outstanding quality of international publications!

Cédric Blanpain receives Liliane Bettencourt Prize for his outstanding quality of international publications!

Adding to his achievements (see article posted July 13th, 2012) and his award for stem cell research, Cédric Blanpain, professor at the ULB, WELBIO IRIBHM investigator and Faculty of Medicine of the ULB, has been announced [...]